William Blair & Company’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

William Blair & Company’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,000	Closed	-$42K	–	2229
2014 Q4	$42K	Buy	+3,000	New	+$46.5K	﹤0.01%	2055
2014 Q1	–	Sell	-5,000	Closed	-$64K	–	2084
2013 Q4	$64K	Sell	5,000 -1,000	-17%	-$11.9K	﹤0.01%	1937
2013 Q3	$60K	Buy	+6,000	New	+$53.4K	﹤0.01%	1978

William Blair & Company's KERX Position: Q4 2018 in Review

William Blair & Company sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 187,900 shares — an estimated $639K sold.

William Blair & Company first reported a position in KERX in Q3 2013 and held it in 9 quarters. The position peaked at $1.37M in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

William Blair & Company reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
William Blair & Company sold 187,900 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $639K.
William Blair & Company first reported a position in Keryx Biopharmaceuticals Inc in Q3 2013 and held it in 9 quarters.
William Blair & Company's Keryx Biopharmaceuticals Inc position peaked at $1.37M in Q3 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on William Blair & Company's 13F filing for Q4 2018, filed 14 Feb 2019.